EditCo

EditCo Bio is a pioneer in the development of CRISPR-engineered cell models and high-throughput gene editing solutions. Originally a spinout of Synthego, EditCo Bio leverages the expertise, technology, and partnerships that are critical for creating a novel, end-to-end CRISPR platform able to accelerate scientific discoveries. They’re dedicated to building out a more accessible research toolkit to make genome engineering easier, faster, and more reliable.

 

To learn more about EditCo : www.editco.bio